A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Phase II Study to Assess the Effects on Atrial and Ventricular Refractoriness of an Intravenous Infusion of AZD2927 in Patients Undergoing an Invasive Electrophysiological Procedure.
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2018
At a glance
- Drugs AZD 2927 (Primary)
- Indications Atrial flutter
- Focus Pharmacodynamics
- 13 Jan 2012 Actual patient number (20) added as reported by ClinicalTrials.gov.
- 13 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 13 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.